Expression of end-binding protein 1 (EB1), a potential response-predictive biomarker for lisavanbulin, in glioblastoma and various other solid tumor types.

Authors

null

Magdalena Skowronska

Institute of Pathology, University of Bern, Bern, Switzerland

Magdalena Skowronska , Crescens Diane Tiu , Alexandar Tzankov , Fatima König , Joanne Lewis , Igor Vivanco , Malte Kleinschmidt , Kirk Beebe , Stephanie Anderson , Felix Bachmann , Marc Engelhardt , Heidi A Lane , Thomas Kaindl , Alexandru C Stan , Elizabeth Ruth Plummer , T.R. Jeffry Evans , Inti Zlobec , Juanita Suzanne Lopez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3118)

DOI

10.1200/JCO.2021.39.15_suppl.3118

Abstract #

3118

Poster Bd #

Online Only

Abstract Disclosures